To improve lives through biologic therapeutics that address significant medical need.
Our team utilizes exceptional science and human resources in both the United States and China to be a therapeutic innovation leader.
RuiYi is focused on the discovery and development of novel biologic therapies in China, including monoclonal antibodies that target G protein coupled receptors (GPCRs). RuiYi’s executive management team has offices in La Jolla, California while all of RuiYi’s discovery efforts are located in Shanghai, China. RuiYi’s research facility is in the Zhangjiang Hi-Tech Park in Pudong Shanghai, China.